ZA202200341B - Antibodies specifically recognizing pseudomonas pcrv and uses thereof - Google Patents

Antibodies specifically recognizing pseudomonas pcrv and uses thereof

Info

Publication number
ZA202200341B
ZA202200341B ZA2022/00341A ZA202200341A ZA202200341B ZA 202200341 B ZA202200341 B ZA 202200341B ZA 2022/00341 A ZA2022/00341 A ZA 2022/00341A ZA 202200341 A ZA202200341 A ZA 202200341A ZA 202200341 B ZA202200341 B ZA 202200341B
Authority
ZA
South Africa
Prior art keywords
antibodies specifically
specifically recognizing
pseudomonas pcrv
recognizing pseudomonas
pcrv
Prior art date
Application number
ZA2022/00341A
Inventor
Maorong Yu
Zhong Li
Chao Wang
Original Assignee
Staidson Beijing Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CN2020/100592 external-priority patent/WO2021004446A1/en
Application filed by Staidson Beijing Biopharmaceuticals Co Ltd filed Critical Staidson Beijing Biopharmaceuticals Co Ltd
Publication of ZA202200341B publication Critical patent/ZA202200341B/en

Links

ZA2022/00341A 2019-07-09 2022-01-06 Antibodies specifically recognizing pseudomonas pcrv and uses thereof ZA202200341B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2019095181 2019-07-09
PCT/CN2020/100592 WO2021004446A1 (en) 2019-07-09 2020-07-07 Antibodies specifically recognizing pseudomonas pcrv and uses thereof

Publications (1)

Publication Number Publication Date
ZA202200341B true ZA202200341B (en) 2022-10-26

Family

ID=83724096

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/00341A ZA202200341B (en) 2019-07-09 2022-01-06 Antibodies specifically recognizing pseudomonas pcrv and uses thereof

Country Status (1)

Country Link
ZA (1) ZA202200341B (en)

Similar Documents

Publication Publication Date Title
EP3759143A4 (en) Anti-tigit antibodies and uses thereof
EP3740224A4 (en) Anti-lilrb antibodies and uses thereof
EP3762030A4 (en) Anti-cd73 antibodies and uses thereof
EP3740508A4 (en) Antibodies and variants thereof against tigit
EP3838289A4 (en) Anti-tigit antibody and uses thereof
EP3891183A4 (en) Anti-claudin antibodies and uses thereof
EP3918323A4 (en) Anti-gal3 antibodies and uses thereof
EP3735427A4 (en) Anti-mct1 antibodies and uses thereof
EP3997127A4 (en) Dll3-targeting antibodies and uses thereof
EP3790586A4 (en) Anti-dll3 antibodies and uses thereof
EP3904382A4 (en) Anti-il-23p19 antibody and uses thereof
EP3768317A4 (en) Anti-il-27 antibodies and uses thereof
EP3962954A4 (en) Anti-galectin-9 antibodies and uses thereof
EP3962956A4 (en) Anti-hvem antibodies and use thereof
EP4071172A4 (en) Anti-lilrb1 antibody and uses thereof
EP4025609A4 (en) Anti-steap1 antibodies and uses thereof
EP3894440A4 (en) Anti-il-27 antibodies and uses thereof
EP3850012A4 (en) Anti-tnfrsf9 antibodies and uses thereof
EP4001308A4 (en) Anti-tigit antibodies and application thereof
EP3774888A4 (en) Anti-phf-tau antibodies and uses thereof
EP3755714A4 (en) Anti-angiopoietin-2 antibodies and uses thereof
IL308382A (en) Novel anti-cd276 antibodies and the uses thereof
IL291550A (en) Anti-il-27 antibodies and uses thereof
IL291546A (en) Anti-kir3dl3 antibodies and uses thereof
IL291280A (en) Anti-cd371 antibodies and uses thereof